Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
RECRUITING
NCT04635111
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
30
Enrollment(s)
8
Study location(s)
OBSERVATIONAL (None)
Hepatotoxicity
Tenosynovial Giant Cell Tumor
ACTIVE_NOT_RECRUITING
NCT03734029
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
557
Enrollment(s)
208
Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
COMPLETED
NCT05804747
A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation
1,204
Enrollment(s)
33
Study location(s)
OBSERVATIONAL (None)
Atrial Fibrillation
RECRUITING
NCT05795101
TRUDI: TDXD+Durva in HER2+/Low IBC
63
Enrollment(s)
3
Study location(s)
INTERVENTIONAL (PHASE2)
Invasive Breast Cancer
Inflammatory Breast Cancer Stage III
HER2-positive Breast Cancer
HER2 Low Breast Adenocarcinoma
Breast Cancer
ACTIVE_NOT_RECRUITING
NCT07113054
A Clinical Trial to Evaluate the Effect of Grapefruit Juice on the PK/PD of Edoxaban
14
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Healthy
COMPLETED
NCT06504719
Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan
312
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Breast Cancer
Metastatic Cancer
NOT_YET_RECRUITING
NCT07130344
PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer
262
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (NA)
Metastatic Breast Cancer
HER 2 Low-expressing Breast Cancer
ACTIVE_NOT_RECRUITING
NCT04488822
A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT
40
Enrollment(s)
9
Study location(s)
INTERVENTIONAL (PHASE3)
Tenosynovial Giant Cell Tumor
16
17
18
19
20